Domenico Serino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Domenico Serino has a total of 123 co-authors. Here are the top co-authors by number of shared publications:
Lucia Fusco
IRCCS Childrens Hosp, Neurol Epilepsy & Movement Disorders Unit, Bambino Gesu, European Reference Network EpiCARE, Rome, Italy
9 shared publications- Federico Vigevano
Department of Paediatric Neurorehabilitation IRCCS San Raffaele Rome Italy
8 shared publications - Nicola Specchio
Neurology, Epilepsy and Movement Disorders Unit, Bambino Gesù Children's Hospital, IRCCS, Full Member of European Reference Network EpiCARE, Rome, Italy
7 shared publications - Simona Cappelletti
Neurology, Epilepsy and Movement Disorders Unit Bambino Gesù Children's Hospital IRCCS, Full Member of European Reference Network on Rare and Complex Epilepsies EpiCARE Rome Italy
4 shared publications - Davide Caputo
Department of Paediatric Neuroscience, European Reference Network EPIcare, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
3 shared publications Giuseppe Pontrelli
Division of Neurology, Bambino Gesù Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy; "Amaducci" Neurology Unit, Department of Neuroscience, University of Bari, Bari, Italy
3 shared publications
Latest Publications
- Open Access
- 17 February 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 177, 110942
Assessing the impact of e-learning in caregiver training on paediatric epilepsy awareness and buccal Midazolam administration: A Scottish quality improvement study
- 17 February 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 177, 110942
Open AccessAssessing the impact of e-learning in caregiver training on paediatric epilepsy awareness and buccal Midazolam administration: A Scottish quality improvement study
- 1 November 2024
- Published by Elsevier in Epilepsy & Behavior
- Vol. 161, 110120
Tonic and tonic-clonic seizures in the first year of life: Insights from electrographic features
- 1 November 2024
- Published by Elsevier in Epilepsy & Behavior
- Vol. 161, 110120
Tonic and tonic-clonic seizures in the first year of life: Insights from electrographic features
- 7 January 2022
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 37, 25-31
Super-refractory status epilepticus (SRSE): A case series of 22 pediatric patients
- 7 January 2022
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 37, 25-31
Super-refractory status epilepticus (SRSE): A case series of 22 pediatric patients
- 1 December 2020
- Published by Elsevier in Epilepsy & Behavior
- Vol. 113, 107531
Three different scenarios for epileptic spasms
- 1 December 2020
- Published by Elsevier in Epilepsy & Behavior
- Vol. 113, 107531
Three different scenarios for epileptic spasms
- Open Access
- 1 July 2019
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 15, 1897-1903
Febrile infection-related epilepsy syndrome (FIRES): prevalence, impact and management strategies
Febrile infection-related epilepsy syndrome (FIRES) is a rare catastrophic epileptic encephalopathy with a yet undefined etiology, affecting healthy children. It is characterized by acute manifestation of recurrent seizures or refractory status epilepticus preceded by febrile illness, but without evidence of infectious encephalitis. To date, the absence of specific biomarkers poses a significant diagnostic challenge; nonetheless, early diagnosis is very important for optimal management. FIRES is mostly irreversible and its sequelae include drug-resistant epilepsy and neuropsychological impairments. The treatment of FIRES represents a significant challenge for clinicians and is associated with low success rates. Early introduction of ketogenic diet seems to represent the most effective and promising treatment. This review aims to highlight the most recent insights on clinical features, terminology, epidemiology, pathogenesis, diagnostic challenges and therapeutic options.
- 1 July 2019
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 15, 1897-1903
Open AccessFebrile infection-related epilepsy syndrome (FIRES): prevalence, impact and management strategies
Febrile infection-related epilepsy syndrome (FIRES) is a rare catastrophic epileptic encephalopathy with a yet undefined etiology, affecting healthy children. It is characterized by acute manifestation of recurrent seizures or refractory status epilepticus preceded by febrile illness, but without evidence of infectious encephalitis. To date, the absence of specific biomarkers poses a significant diagnostic challenge; nonetheless, early diagnosis is very important for optimal management. FIRES is mostly irreversible and its sequelae include drug-resistant epilepsy and neuropsychological impairments. The treatment of FIRES represents a significant challenge for clinicians and is associated with low success rates. Early introduction of ketogenic diet seems to represent the most effective and promising treatment. This review aims to highlight the most recent insights on clinical features, terminology, epidemiology, pathogenesis, diagnostic challenges and therapeutic options.
- 1 January 2018
- Published by Elsevier in Brain and Development
- Vol. 40 (1) , 77-80
Cerebellar fits in the 2000s
- 1 January 2018
- Published by Elsevier in Brain and Development
- Vol. 40 (1) , 77-80
Cerebellar fits in the 2000s
Symptomatic and presumed symptomatic focal epilepsies in childhood: An observational, prospective multicentre study
Summary: Objective: To describe the clinical, neuropsychological, and psychopathologic features of a cohort of children with a new diagnosis of symptomatic or presumed symptomatic focal epilepsy at time of recruitment and through the first month. The selected population will be followed for 2–5 years after enrollment to investigate the epilepsy course and identify early predictors of drug resistance.Methods: In this observational, multicenter, nationwide study, children (age 1 month–12.9 years) with a new diagnosis of symptomatic or presumed symptomatic focal epilepsy were consecutively enrolled in 15 Italian tertiary childhood epilepsy centers. Inclusion criteria were as follows: (1) diagnosis of symptomatic focal epilepsy due to acquired and developmental etiologies, and presumed symptomatic focal epilepsy; (2) age at diagnosis older than 1 month and 3 to 6 years, and >6 years. Clinical, electroencephalography (EEG), neuroimaging, and neuropsychological variables were identified for statistical analyses.Results: Two hundred fifty‐nine children were enrolled (116 female and 143 male). Median age: 4.4 years (range 1 month–12.9 years); 46.0% (n = 119) of children were younger than 3 years, 24% (61) from 3 to 6 years of age, and 30% (79) older than 6 years. Neurologic examination findings were normal in 71.8%. Brain magnetic resonance imaging (MRI) was abnormal in 59.9%. Children age ≤3 years experienced the highest seizure frequency in the first month after recruitment (p < 0.0001). Monotherapy in the first month was used in 67.2%. Cognitive tests at baseline revealed abnormal scores in 30%; behavioral problems were present in 21%. At multivariate analysis, higher chances to exhibit more than five seizures in the first month after epilepsy onset was confirmed for younger children and those with temporal lobe epilepsy.Significance: In this prospective cohort study, an extensive characterization of epilepsy onset in children with symptomatic or presumed symptomatic focal epilepsies is reported in relation to the age group and the localization of the epileptogenic zone.
Symptomatic and presumed symptomatic focal epilepsies in childhood: An observational, prospective multicentre study
Summary: Objective: To describe the clinical, neuropsychological, and psychopathologic features of a cohort of children with a new diagnosis of symptomatic or presumed symptomatic focal epilepsy at time of recruitment and through the first month. The selected population will be followed for 2–5 years after enrollment to investigate the epilepsy course and identify early predictors of drug resistance.Methods: In this observational, multicenter, nationwide study, children (age 1 month–12.9 years) with a new diagnosis of symptomatic or presumed symptomatic focal epilepsy were consecutively enrolled in 15 Italian tertiary childhood epilepsy centers. Inclusion criteria were as follows: (1) diagnosis of symptomatic focal epilepsy due to acquired and developmental etiologies, and presumed symptomatic focal epilepsy; (2) age at diagnosis older than 1 month and 3 to 6 years, and >6 years. Clinical, electroencephalography (EEG), neuroimaging, and neuropsychological variables were identified for statistical analyses.Results: Two hundred fifty‐nine children were enrolled (116 female and 143 male). Median age: 4.4 years (range 1 month–12.9 years); 46.0% (n = 119) of children were younger than 3 years, 24% (61) from 3 to 6 years of age, and 30% (79) older than 6 years. Neurologic examination findings were normal in 71.8%. Brain magnetic resonance imaging (MRI) was abnormal in 59.9%. Children age ≤3 years experienced the highest seizure frequency in the first month after recruitment (p < 0.0001). Monotherapy in the first month was used in 67.2%. Cognitive tests at baseline revealed abnormal scores in 30%; behavioral problems were present in 21%. At multivariate analysis, higher chances to exhibit more than five seizures in the first month after epilepsy onset was confirmed for younger children and those with temporal lobe epilepsy.Significance: In this prospective cohort study, an extensive characterization of epilepsy onset in children with symptomatic or presumed symptomatic focal epilepsies is reported in relation to the age group and the localization of the epileptogenic zone.
- 1 December 2015
- Published by Wiley in Epileptic Disorders
- Vol. 17 (4) , 384-396
Peri‐ictal water drinking: a rare automatic behaviour in temporal lobe epilepsy
Peri‐ictal water drinking (PIWD) has been reported as the action of drinking during or within two minutes of an electroclinical seizure. It is considered a peri‐ictal vegetative symptom, evident both during childhood and adulthood epilepsy. The aim of this paper was to describe the clinical and electroencephalographic features of two new adult subjects suffering from symptomatic temporal lobe epilepsy with episodes of PIWD recorded by VIDEO‐EEG and to review literature data in order to better define this peculiar event during seizures, a rare and probably underestimated semiological sign. To date, 51 cases with focal epilepsy and seizures associated with PIWD have been reported. All patients presented with temporal lobe epilepsy. All cases but one had symptomatic epilepsy. Most of the patients had an involvement of the right hemisphere. Water drinking was reported as an ictal sign in the majority of patients, and less frequently was reported as postictal. We believe that PIWD might be considered a rare automatic behaviour, like other automatisms. Automatisms are more frequently described in patients with temporal lobe epilepsy. PIWD was reported also to have lateralizing significance in the non‐dominant temporal lobe, however, because of its rarity, this finding remains unclear.
- 1 December 2015
- Published by Wiley in Epileptic Disorders
- Vol. 17 (4) , 384-396
Peri‐ictal water drinking: a rare automatic behaviour in temporal lobe epilepsy
Peri‐ictal water drinking (PIWD) has been reported as the action of drinking during or within two minutes of an electroclinical seizure. It is considered a peri‐ictal vegetative symptom, evident both during childhood and adulthood epilepsy. The aim of this paper was to describe the clinical and electroencephalographic features of two new adult subjects suffering from symptomatic temporal lobe epilepsy with episodes of PIWD recorded by VIDEO‐EEG and to review literature data in order to better define this peculiar event during seizures, a rare and probably underestimated semiological sign. To date, 51 cases with focal epilepsy and seizures associated with PIWD have been reported. All patients presented with temporal lobe epilepsy. All cases but one had symptomatic epilepsy. Most of the patients had an involvement of the right hemisphere. Water drinking was reported as an ictal sign in the majority of patients, and less frequently was reported as postictal. We believe that PIWD might be considered a rare automatic behaviour, like other automatisms. Automatisms are more frequently described in patients with temporal lobe epilepsy. PIWD was reported also to have lateralizing significance in the non‐dominant temporal lobe, however, because of its rarity, this finding remains unclear.
- 1 August 2015
- Published by Elsevier in Sleep Medicine
- Vol. 16 (8) , 1014-1016
Epileptic hypnagogic jerks mimicking repetitive sleep starts
- 1 August 2015
- Published by Elsevier in Sleep Medicine
- Vol. 16 (8) , 1014-1016
Epileptic hypnagogic jerks mimicking repetitive sleep starts
- 1 July 2015
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 19 (4) , 453-463
Paediatric anti-N-methyl-d-aspartate receptor encephalitis: The first Italian multicenter case series
- 1 July 2015
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 19 (4) , 453-463
Paediatric anti-N-methyl-d-aspartate receptor encephalitis: The first Italian multicenter case series